Anixa Biosciences…announced that the United States Patent and Trademark Ofﬁce (USPTO) will issue U.S. Patent Number 12,472,205 on November 18, 2025, covering key aspects of the Company&#39;s breast cancer vaccine technology

alpha-lactalbumin vaccine - Anixa Biosci, Cleveland Clinic

Nov 12, 2025